In dermal wound trials, TB4 has been explored for accelerating re-epithelialization, and is under investigation in ocular injury models (e.g., corneal wound healing)
However, this represents an off-label use without established protocols or evidence base
Benefits Influencing healing through distinct biological mechanisms, BPC-157 and TB4 may combine for synergistic regenerative effects
When combined with vitamin B12, this compounded therapy addresses both appetite regulation and the energy depletion some patients experience during weight loss
Be careful to avoid air bubbles
Common experiences after the first injection include: Mild soreness or redness at the injection site (usually resolves within 12 days) Slight improvement in energy levels or mood No immediate noticeable change (particularly common if deficiency is severe) Rarely, mild side effects such as headache or dizziness Some patients report their urine becoming brighter or more intensely coloured following injection, which occurs because excess B12 is excreted renally